Human tumor antigens for cancer vaccine development, Immunol. Rev, vol.170, p.85, 1999. ,
Melanoma-associated antigens recognized by cytotoxic T lymphocytes, APMIS, vol.106, p.665, 1998. ,
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100, J. Immunother, vol.23, p.487, 2000. ,
Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma, J. Immunother, vol.24, p.66, 2001. ,
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4 ? T lymphocytes of patients with NY-ESO-1-expressing melanoma, J. Exp. Med, vol.191, p.625, 2000. ,
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34 ? hematopoietic progenitor cells, Int. J. Cancer, vol.86, p.385, 2000. ,
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens, J. Natl. Cancer Inst, vol.90, p.1894, 1998. ,
Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides, Cancer Res, vol.56, p.4749, 1996. ,
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection, Eur. J. Immunol, vol.25, p.340, 1995. ,
Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance, Immunol. Today, vol.16, p.487, 1995. ,
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, Eur. J. Immunol, vol.31, 2001. ,
HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry, Transplantation, vol.64, p.1017, 1997. ,
Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex, Nature, vol.355, p.641, 1992. ,
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.178, p.489, 1993. ,
Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure, Proc. Natl. Acad. Sci, vol.84, p.3365, 1987. ,
Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes, Methods, vol.12, p.125, 1997. ,
Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues, J. Immunol, vol.154, p.5951, 1995. ,
HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules, Int. Immunol, vol.6, p.255, 1994. ,
A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes, Eur. J. Immunol, vol.30, p.3411, 2000. ,
A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes, Int. J. Cancer, vol.83, p.755, 1999. ,
A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes, Tissue Antigens, vol.57, p.103, 2001. ,
Peptide motifs of HLA-B35 and -B37 molecules, Immunogenetics, vol.38, p.161, 1993. ,
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J. Immunol, vol.160, p.1750, 1998. ,
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens, J. Immunol, vol.162, p.1739, 1999. ,
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression, J. Immunol, vol.154, p.3961, 1995. ,
Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells, J. Immunol, vol.158, p.1796, 1997. ,
Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1, Int. J. Cancer, vol.82, p.442, 1999. ,
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes, J. Immunol, vol.166, p.2871, 2001. ,
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8 ? T cells in the context of HLA-B51, Cancer Immunol, vol.2, p.12, 2002. ,
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele, Proc. Natl. Acad. Sci. USA, vol.97, p.10917, 2000. ,
A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules, Tissue Antigens, vol.56, p.77, 2000. ,